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Introduction
Peritoneal carcinomatosis is a major source of morbidity and mortality in patients with
advanced abdominal neoplasms. Intraperitoneal chemotherapy is an area of intense
interest given its efficacy in ovarian cancer. However, large peritoneal metastases
(>0.5cm3) with adequate blood flow have high interstitial fluid pressure, which inhibits
intratumoral drug distribution [1]. To study drug penetration and its influencing
factors, reliable in vivo models that mimic peritoneal carcinomatosis are crucial [2]. By
applying tissue engineering we successfully biomimicked a peritoneal ovarian tumour
and its environment in mice. Functional blood vessel formation was evaluated with
contrast-enhanced µCT. 
Methods
A mixture of ovarian cancer cells and cancer-associated fibroblasts was seeded on
gelatine coated 3D PLA scaffold of 0.1 cm3 [3]. After 3 weeks of in vitro culture, the
tumour scaffolds (TS) and blank scaffolds (BS) were implanted on the inside of the
peritoneal wall. Functional blood vessel formation was assessed with µCT. Four mice
were IV injected with Exitron 12000 (Miltenyi Biotec). Contrast enhanced µCT imaging
was performed on the X-CUBE cone beam µCT (MOLECUBES NV, Belgium). The high
resolution protocol was used with the following acquisition parameters: one bed
position (70x40 mm FOV), circular trajectory with four continuous rotations, 720
projections/rotation, 460 µA tube current and 50 kVp tube voltage, resulting in a four
minutes acquisition time. Acquisitions were reconstructed into an 800x800x800 matrix
with 50µm voxel size using the FDK algorithm [4]. Quantification was performed by
calculating vessel volume (mm3). Additionally, in vivo cell growth was longitudinally
monitored using bioluminescent imaging. 
Results
The tumour scaffolds cause only limited animal morbidity. Within four weeks the
scaffolds were completely incorporated in the host mice. Functional blood vessels from
the peritoneal wall enter the tumour scaffolds, visual on µCT (see Figure, A).
Quantification of the vessel volume showed more vessel formation in TS compared to
BS (Figure, B). Additionally, it was demonstrated that the blood vessel volume is
correlated with tumour cell growth within the scaffold (Figure, C).
Conclusions
We can conclude that µCT imaging is a useful tool to assess vessel formation in TS.
The TS become vascularized and show cancer cell growth proportional with
vascularization as evidenced by contrast-enhanced µCT and bioluminescence
monitoring, respectively. This model opens new opportunities for therapy evaluation of
peritoneal carcinomatosis and its tumour environment.
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Figure 1:
(A) Contrast-enhanced µCT of tumour scaffold (TS) and blank scaffold (BS). (B) Quantification of
vessel volumes. (C) Correlation between vessel volumes and tumour cell growth.
